1. Home
  2. ORN vs GOSS Comparison

ORN vs GOSS Comparison

Compare ORN & GOSS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ORN
  • GOSS
  • Stock Information
  • Founded
  • ORN 1994
  • GOSS 2015
  • Country
  • ORN United States
  • GOSS United States
  • Employees
  • ORN N/A
  • GOSS N/A
  • Industry
  • ORN Military/Government/Technical
  • GOSS Biotechnology: Pharmaceutical Preparations
  • Sector
  • ORN Industrials
  • GOSS Health Care
  • Exchange
  • ORN Nasdaq
  • GOSS Nasdaq
  • Market Cap
  • ORN 339.4M
  • GOSS 347.8M
  • IPO Year
  • ORN 2007
  • GOSS 2019
  • Fundamental
  • Price
  • ORN $7.44
  • GOSS $2.47
  • Analyst Decision
  • ORN Strong Buy
  • GOSS Strong Buy
  • Analyst Count
  • ORN 2
  • GOSS 4
  • Target Price
  • ORN $11.25
  • GOSS $8.50
  • AVG Volume (30 Days)
  • ORN 425.7K
  • GOSS 3.1M
  • Earning Date
  • ORN 10-29-2025
  • GOSS 08-05-2025
  • Dividend Yield
  • ORN N/A
  • GOSS N/A
  • EPS Growth
  • ORN N/A
  • GOSS N/A
  • EPS
  • ORN 0.27
  • GOSS N/A
  • Revenue
  • ORN $837,494,000.00
  • GOSS $40,237,000.00
  • Revenue This Year
  • ORN $4.83
  • GOSS N/A
  • Revenue Next Year
  • ORN $8.34
  • GOSS $30.65
  • P/E Ratio
  • ORN $26.98
  • GOSS N/A
  • Revenue Growth
  • ORN 15.85
  • GOSS N/A
  • 52 Week Low
  • ORN $4.64
  • GOSS $0.66
  • 52 Week High
  • ORN $9.95
  • GOSS $2.65
  • Technical
  • Relative Strength Index (RSI)
  • ORN 51.54
  • GOSS 68.08
  • Support Level
  • ORN $6.88
  • GOSS $2.38
  • Resistance Level
  • ORN $7.67
  • GOSS $2.65
  • Average True Range (ATR)
  • ORN 0.30
  • GOSS 0.15
  • MACD
  • ORN 0.14
  • GOSS 0.03
  • Stochastic Oscillator
  • ORN 80.89
  • GOSS 76.67

About ORN Orion Group Holdings Inc. Common

Orion Group Holdings Inc is a specialty construction company serving the infrastructure, industrial, and building sectors, providing services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its marine segment and its concrete segment. Its marine segment provides construction and dredging services relating to marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar and mesh across the light commercial, structural and other associated business areas.

About GOSS Gossamer Bio Inc.

Gossamer Bio Inc is a clinical-stage biopharmaceutical company. It focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology. The company pipeline products include Seralutinib, which address the cellular overgrowth, fibrosis, and vascular remodeling which underlie PAH (pulmonary arterial hypertension); GB004, for the treatment of inflammatory bowel disease, including ulcerative colitis and Crohn's disease; GB1275, for the treatment of oncology indications; and GB001, for the treatment of moderate-to-severe eosinophilic asthma.

Share on Social Networks: